34650914|t|OLFML2A Downregulation Inhibits Glioma Proliferation Through Suppression of Wnt/beta-Catenin Signaling.
34650914|a|Glioma is a highly heterogeneous and lethal tumor with an extremely poor prognosis. Through analysis of TCGA data, we identified that OLFML2A is a key promotor of gliomagenesis. However, the molecular function of OLFML2A and its underlying mechanism of action in glioma remain unclear. In this study, we found that OLFML2A expression was significantly upregulated in glioma specimens and positively correlated with pathological grades in glioma patients. Moreover, Kaplan-Meier survival analysis of TCGA data revealed that glioma patients with higher OLFML2A expression had shorter overall survival. Importantly, OLFML2A knockdown in glioma cells inhibited cell proliferation and promoted apoptosis. Mechanistically, OLFML2A downregulation inhibits Wnt/beta-catenin signaling by upregulating amyloid precursor protein (APP) expression and reducing stabilized beta-catenin levels, leading to the repression of MYC, CD44, and CSKN2A2 expression. Furthermore, OLFML2A downregulation suppressed the growth of transplanted glioma subcutaneously and intracranially by inhibiting Wnt/beta-catenin pathway-dependent cell proliferation. By uncovering the oncogenic effects in human and rodent gliomas, our data support OLFML2A as a potential therapeutic target for glioma.
34650914	0	7	OLFML2A	Gene	169611
34650914	32	38	Glioma	Disease	MESH:D005910
34650914	80	92	beta-Catenin	Gene	1499
34650914	104	110	Glioma	Disease	MESH:D005910
34650914	148	153	tumor	Disease	MESH:D009369
34650914	238	245	OLFML2A	Gene	169611
34650914	267	280	gliomagenesis	Disease	
34650914	317	324	OLFML2A	Gene	169611
34650914	367	373	glioma	Disease	MESH:D005910
34650914	419	426	OLFML2A	Gene	169611
34650914	471	477	glioma	Disease	MESH:D005910
34650914	542	548	glioma	Disease	MESH:D005910
34650914	549	557	patients	Species	9606
34650914	627	633	glioma	Disease	MESH:D005910
34650914	634	642	patients	Species	9606
34650914	655	662	OLFML2A	Gene	169611
34650914	717	724	OLFML2A	Gene	169611
34650914	738	744	glioma	Disease	MESH:D005910
34650914	821	828	OLFML2A	Gene	169611
34650914	857	869	beta-catenin	Gene	1499
34650914	896	921	amyloid precursor protein	Gene	351
34650914	963	975	beta-catenin	Gene	1499
34650914	1013	1016	MYC	Gene	4609
34650914	1018	1022	CD44	Gene	960
34650914	1061	1068	OLFML2A	Gene	169611
34650914	1122	1128	glioma	Disease	MESH:D005910
34650914	1181	1193	beta-catenin	Gene	1499
34650914	1271	1276	human	Species	9606
34650914	1288	1295	gliomas	Disease	MESH:D005910
34650914	1314	1321	OLFML2A	Gene	169611
34650914	1360	1366	glioma	Disease	MESH:D005910
34650914	Negative_Correlation	1499	169611
34650914	Negative_Correlation	169611	4609
34650914	Negative_Correlation	169611	351
34650914	Positive_Correlation	169611	960
34650914	Association	MESH:D005910	169611
34650914	Association	MESH:D005910	1499

